Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes

Keyphrases

• HLA-A2 100%
• Immune Recognition 100%
• CTL Epitope 100%
• Human Immunodeficiency Virus Type 1 (HIV-1) 100%
• Epitope 33%
• Epitope Peptide 22%
• Immunogenicity 22%
• Subdominant Epitopes 22%
• Artificial Neural Network 22%
• Vaccine Epitopes 22%
• Virus 22%
• Transgenic Mice 11%
• MHC Class II 11%
• Vaccine Approaches 11%
• CD8+ T Cells 11%
• Immune Response 11%
• New Humanities 11%
• HIV Variant 11%
• Immunogenic 11%
• Publicly Available 11%
• Novel Vaccines 11%
• Binding Peptide 11%
• Cytotoxic Response 11%
• Intermediate Bindings 11%
• IFNγ Response 11%
• Binding Affinity 11%
• Regulatory Proteins 11%
• Accessory Protein 11%
• Protective Immunity 11%
• Non-immunogenic 11%
• Protein Sequence 11%
• Vaccine Development 11%
• Binder 11%

Immunology and Microbiology

• Epitope 100%
• Human Immunodeficiency Virus 1 100%
• Antigen Recognition 100%
• Peptides 21%
• Artificial Neural Network 14%
• Immunogenicity 14%
• Virus 14%
• Binding Affinity 7%
• Immune Response 7%
• Human immunodeficiency virus 7%
• Transgenic Mouse 7%
• Amino Acid Sequence 7%
• Cytotoxic T-Cell 7%